Analytical Data
-
Gene name
MTCH2
- Application
-
Alternative Names
MIMP; Met-induced mitochondrial protein
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9Y6C9
-
Expression Region
Gln29~Gly174
-
Molecular Weight
20kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MTCH2, or mitochondrial carrier protein 2, is a member of the mitochondrial carrier family, playing a crucial role in mitochondrial function and cellular energy metabolism. Recent research has highlighted its involvement in regulating apoptosis, mitochondrial dynamics, and metabolic pathways, which are critical for maintaining cellular homeostasis. Dysregulation of MTCH2 has been linked to various diseases, including neurodegenerative disorders and cancer, underscoring its potential as a therapeutic target. Investigating the structure and function of MTCH2 through recombinant protein studies is essential for understanding its biological roles and interactions within the mitochondria. By expressing MTCH2 as a recombinant protein in various systems, researchers can explore its biochemical properties, binding interactions, and functional implications in mitochondrial physiology. This foundational knowledge could pave the way for novel interventions aimed at modulating MTCH2 activity, thereby offering new insights into the treatment of mitochondrial-related diseases. Overall, the study of MTCH2 as a recombinant protein not only enhances our understanding of mitochondrial biology but also opens avenues for therapeutic developments in conditions where mitochondrial function is compromised.
